Aspen Biosciences
Private Company
Funding information not available
Overview
Aspen Biosciences operates at the intersection of biologics manufacturing and drug discovery software. Originally focused on producing recombinant antibodies and proteins, the company now offers a suite of software products and consulting services designed to help R&D organizations manage data, integrate target information, and connect with investors. Its business model appears to be a hybrid of services and platform software, catering primarily to private drug discovery companies. The company is privately held, with its headquarters located in San Diego, California.
Technology Platform
Provides a suite of software applications and consulting services for drug discovery data management, target integration, and business intelligence (Pharm2Market platform).
Opportunities
Risk Factors
Competitive Landscape
Competes with large commercial life science informatics providers (e.g., Dotmatics, Benchling), custom software developers, and consulting firms. Differentiation hinges on its integrated approach combining scientific data tools with business development intelligence.